Active Ingredient History
Norfloxacin is an antibacterial agent, It inhibits inhibits DNA synthesis by inhibiting DNA gyrase enzyme. Norfloxacin was approved in 1986 for treatment of urinary tract infections, gynecological infections, prostatitis, gonorhhea and bladder infections. In ophtalmology, norfloxacin is used for treatment of conjunctivitus. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Conjunctivitis (approved 1991)
Gonorrhea (approved 1986)
Prostatitis (approved 1986)
Urinary Tract Infections (approved 1986)
Anti-Bacterial Agents (Phase 1)
Ascites (Phase 3)
Conjunctivitis, Bacterial (Phase 3)
Cystitis (Phase 3)
Esophageal and Gastric Varices (Phase 3)
Fibrosis (Phase 4)
Hepatic Insufficiency (Phase 1)
Hepatopulmonary Syndrome (Phase 2)
Hepatorenal Syndrome (Phase 4)
Kidney Failure, Chronic (Phase 1)
Liver Cirrhosis (Phase 3)
Peritonitis (Phase 4)
Pneumonia, Ventilator-Associated (Phase 2/Phase 3)
Urinary Tract Infections (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue